Rafał Krygier
State University of Applied Sciences in Konin(PL)
Publications by Year
Research Areas
Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, HIV/AIDS drug development and treatment, Systemic Lupus Erythematosus Research
Most-Cited Works
- → Treatment of HCV infection in Poland at the beginning of the interferon‐free era—the EpiTer‐2 study(2018)27 cited
- → Prevalence of HCV genotypes in Poland – the EpiTer study(2016)24 cited
- → Changes of patient profile, treatment effectiveness and safety during 4 years access to interferon-free therapy for hepatitis C virus infection(2020)24 cited
- → Efficacy of HCV treatment in Poland at the turn of the interferon era – the EpiTer study(2016)23 cited
- → Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics(2021)19 cited
- → Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA(2020)19 cited
- → Real‐world effectiveness and safety of direct‐acting antivirals in patients with cirrhosis and history of hepatic decompensation: Epi‐Ter2 Study(2021)17 cited
- → Real life results of direct acting antiviral therapy for HCV infection in HIV–HCV-coinfected patients: Epi-Ter2 study(2019)15 cited
- → Is an 8‐week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real‐world experience?(2020)13 cited
- → Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study(2021)13 cited